Results 181 to 190 of about 50,225 (239)
Ototoxicity in Cancer Therapies
Oral Diseases, EarlyView.
Sady Selaimen da Costa +2 more
wiley +1 more source
Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis
Abstract Objective To conduct a systematic review and meta‐analysis to assess the association between type 2 diabetes and hearing loss. Data Sources Search conducted in PubMed and Scopus databases for articles published between January 2019 and April 2024.
Miguel Caballero‐Borrego +1 more
wiley +1 more source
Abstract Objective Cisplatin is a chemotherapeutic agent with the undesirable side effect of ototoxicity. Transtympanic injections of antioxidant formulations may provide local otoprotection. We tested a novel antioxidant‐eluting microparticle for its otoprotective capability from systemic cisplatin as measured by cochlear electrophysiology.
Eric Michael Smith +3 more
wiley +1 more source
Speech Analysis Using An Analog Cochlea [PDF]
J. Ryland Mundie, Thomas J. Moore
openalex +1 more source
ABSTRACT Purpose Children with central nervous system (CNS) tumors are prone to treatment‐related hearing loss (HL) and subsequent functional impairment. This study reports a dedicated population‐based analysis of CNS tumor‐specific rates and predictors of early severe HL.
Hallie Coltin +13 more
wiley +1 more source
Characteristic Nature of Oxygen Consumption of the Cochlea in Guinea Pig
Masayoshi Oda, JUNICHI YOSHIHIRO
openalex +2 more sources
Intracellular and extracellular dc potentials in the cochlea of the alligator lizard [PDF]
Thomas Weiß +2 more
openalex +1 more source
ABSTRACT Many studies have proposed various comparative genomic methods to probe the molecular basis for adaptive functional convergence between species, conventionally by detecting the convergence of amino acid states between orthologous protein sequences of these species or lineages.
Shanshan Chen, Zhengting Zou
wiley +1 more source
EXPERIMENTAL STUDIES ON THE OXYGEN CONSUMPTION OF THE COCHLEA OF GUINEA PIG TO PURE TONE
JUNICHI YOSHIHIRO
openalex +2 more sources
Our mouse model with a c.259G>A transition in PRPS1 showed a significant decrease in the number of hair cells and SGN counts at 48 weeks of age and a reduction in Prps1 enzymatic activity in the KI mouse. This model will serve as a valuable tool for developing therapeutic strategies.
Denise Yan +6 more
wiley +1 more source

